Clinical trial NCT05367531: Assessment of Injectable Medication Platforms
Official title: Quantitative Assessment of Injectable Medication Delivery Practices
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Overdose Antidote
Bleeding
Allergic Reaction
Keywords: autoinjector
needle
syringe
medication
Lead sponsor: Canadian Forces Health Services Centre Ottawa
Sponsor class: OTHER
First posted: 2022-05-10
Enrollment: 30
Sex: ALL
Minimum age (years): 18
Maximum age (years): 85
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: For each scenario participants will be asked to administer/inject the "medication" (likely saline or air) using various methods: 1) standard protocol , 2) Autoinjector 3) Pre-filled syringes. For each scenario the appropriate medication administration type will have to be selected amongst groups of options: 1) autoinjectors equivalents (ie medication, needle and syringe attached) 2) prefilled syringes where a needle is attached prior to administration; and 3) standard protocol (i.e. drawing medication from the vial and injecting via syringe/22 gauge needle). Medications options will include 1) Naloxone (opioid overdose) 2) Epinephrine (anaphylaxis) 3) Tranexamic acid (bleeding).
Primary purpose: OTHER

Brief summary: Background:

While medical advances for in-hospital care rapidly evolve, a mainstay of effective pre-hospital care remains the ability to treat medical emergencies such as anaphylaxis, prolonged seizure, overdose, or uncontrolled bleeding, through rapid administration of appropriate medication. Autoinjectors are used globally to deliver medications in a timely manner, often in environments where immediate access to medical facilities is limited. Rapid administration of intramuscular medication delivery is essential where oral or intravenous delivery is either not possible or ineffective. The purpose of the proposed study seeks to determine the efficiency various types of medication injection administration.

Detailed description: Research Objective:

To understand the efficiency of injectable medication delivery in the Canadian Forces and civilian world for improved care delivery in military and pre-hospital environments.

Participants:

Approximately thirty (30) participants will be recruited for the study.

Methods:

Data will be obtained on the technical comparison of efficiency for pre-filled syringes to the current standards of administration. The timing and accuracy for administering saline to an inanimate object using the traditional methods versus a pre-filled medication syringes will be compared.

Risks and Risk Mitigation:

The participants in this study are all practicing military personnel who are able to give free and informed consent. To reduce undue influence, LCol Meredith and Dr Gupta will not be involved in recruitment. As a result, these participants are a low vulnerability group. The risk of any adverse events is low since data scenarios, and participants may choose to skip any questions or scenarios that participants do not wish to do. Investigators will remind all participants that their participation is voluntary, and that they may choose to withdraw or stop at any time.

Benefits and Military Significance:

The proposed study will be the first of its kind to assess the efficiency of various injectable medication delivery platforms. This data will provide a background for improving injectable drug delivery practices in various setting (eg military and pre-hospital settings), including the potential to inform novel medical device development.

Eligibility criteria: Inclusion Criteria:

* any participant over the age of 18 able to provide consent

Exclusion Criteria:

* only participants with pre specified conditions impacting cognitive and/or manual dexterity will be excluded
* recent substance use
* non health care workers injection with experience with medication injection in last 12 months

Primary outcomes:
measure: Change in medication Injection/delivery time for each trial
timeFrame: immediately after intervention
Secondary outcomes:
measure: Number of injection failures and/or injuries associated with each trial
timeFrame: immediately after intervention
measure: Perceived difficulty of injection based on type of system
timeFrame: immediately after intervention
Other outcomes:
Locations:
city: Ottawa
country: Canada
facility: Canadian Forces
state: Ontario
Study officials:
affiliation: CAF
name: Gaurav Gupta, MD
role: PRINCIPAL_INVESTIGATOR
References: